ArticleOpen forum infectious diseases2021

Superior Outcomes With Continuing Tenofovir Versus Switching to Zidovudine in Second-Line Antiretroviral Therapy in Haiti.

Samuel Pierre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.